These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 18565690)

  • 1. [Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus].
    Farah-Klibi F; Ben Hamouda S; Ben Romdhane S; Sfar R; Koubaa A; Ben Jilani S; Zermani R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Sep; 37(5):457-62. PubMed ID: 18565690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of CD10 and h-Caldesmon in the distinction of smooth muscle tumors of the uterus and endometrial stromal sarcoma.
    Saraydaroglu O; Ozuysal S; Kasap M; Ozerkan K
    Saudi Med J; 2008 Sep; 29(9):1349-50. PubMed ID: 18813428
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of myocardin in the classification of mesenchymal tumors of the uterus.
    Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
    Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant].
    Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M
    Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
    Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
    Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
    Chu PG; Arber DA; Weiss LM; Chang KL
    Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
    Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
    Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
    Oliva E; Young RH; Amin MB; Clement PB
    Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma.
    Zhao W; Cui M; Zhang R; Shen X; Xiong X; Ji X; Tao L; Jia W; Pang L; Sun Z; Wang C; Zou H
    BMC Cancer; 2021 Sep; 21(1):1047. PubMed ID: 34556086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
    Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
    Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus.
    de Leval L; Waltregny D; Boniver J; Young RH; Castronovo V; Oliva E
    Am J Surg Pathol; 2006 Mar; 30(3):319-27. PubMed ID: 16538051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma.
    Rush DS; Tan J; Baergen RN; Soslow RA
    Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases.
    Abeler VM; Nenodovic M
    Int J Gynecol Pathol; 2011 May; 30(3):236-43. PubMed ID: 21464730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Highly cellular leiomyoma of uterus: a comparative morphologic and immunohistochemical study of endometrial stromal tumors].
    Liao X; Wang Y; Yue C; Liu Y; Wang H; Dai L; Hui Y
    Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):396-400. PubMed ID: 12485478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.
    Chu P; Arber DA
    Am J Clin Pathol; 2000 Mar; 113(3):374-82. PubMed ID: 10705818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
    Soslow RA; Ali A; Oliva E
    Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
    Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
    Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of morphologic and immunohistochemical patterns in the diagnosis of undifferentiated endometrial sarcoma].
    Stolnicu S; Rădulescu D; Mocan S; Pantazescu A; Coroş M
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(4):791-6. PubMed ID: 16004219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.
    Hwang H; Matsuo K; Duncan K; Pakzamir E; Pham HQ; Correa A; Fedenko A; Mhawech-Fauceglia P
    J Clin Pathol; 2015 Sep; 68(9):710-7. PubMed ID: 25991737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
    Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
    Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.